Analytical Data
-
Gene name
GLRa2
- Application
-
Alternative Names
GLRa2；Glycine receptor subunit alpha-2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P23416
-
Expression Region
1-452aa
-
AA Sequence
MNRQLVNILTALFAFFLETNHFRTAFCKDHDSRSGKQPSQTLSPSDFLDKLMGRTSGYDARIRPNFKGPPVNVTCNIFINSFGSVTETTMDYRVNIFLRQQWNDSRLAYSEYPDDSLDLDPSMLDSIWKPDLFFANEKGANFHDVTTDNKLLRISKNGKVLYSIRLTLTLSCPMDLKNFPMDVQTCTMQLESFGYTMNDLIFEWLSDGPVQVAEGLTLPQFILKEEKELGYCTKHYNTGKFTCIEVKFHLERQMGYYLIQMYIPSLLIVILSWVSFWINMDAAPARVALGITTVLTMTTQSSGSRASLPKVSYVKAIDIWMAVCLLFVFAALLEYAAVNFVSRQHKEFLRLRRRQKRQNKEEDVTRESRFNFSGYGMGHCLQVKDGTAVKATPANPLPQPPKDGDAIKKKFVDRAKRIDTISRAAFPLAFLIFNIFYWITYKIIRHEDVHKK
-
Molecular Weight
52.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GLRa2 (Glycoprotein-like receptor A2) is a member of the G protein-coupled receptor (GPCR) family, which plays a crucial role in various physiological processes, including cell signaling and immune responses. Research into GLRa2 has gained momentum due to its potential implications in drug discovery and therapeutic applications. The receptor is known to interact with various ligands, influencing pathways that could be pivotal in diseases such as cancer and autoimmune disorders. Moreover, understanding its structure and function could provide insights into the molecular mechanisms underlying these diseases, enabling the development of more targeted treatments. Recent advances in recombinant protein technology have facilitated the expression and purification of GLRa2, allowing researchers to conduct detailed studies on its biochemical properties and signaling mechanisms. This has opened new avenues for exploring its role in health and disease, highlighting the importance of GLRa2 as a target for innovative therapeutic strategies. Overall, the study of GLRa2 recombinant proteins is crucial for elucidating cellular mechanisms and advancing pharmacological research.
